Oncology Nutrition Market
A recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics.
After conducting thorough research on the historical and current growth parameters of the Oncology Nutrition Market, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The Oncology Nutrition Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Cancer Type
Head & Neck Cancer
Stomach & Gastrointestinal Cancers
Blood Cancer
Breast Cancer
Lung Cancer
Other cancers
By End Use
Hospitals
Home Care
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the Oncology Nutrition Market includes the market proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Oncology Nutrition Market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Oncology Nutrition Market in this chapter, which will help them understand basic information about the Oncology Nutrition Market. This section also highlights the inclusions and exclusions, which help the reader, understand the scope of the Oncology Nutrition Market report.
Chapter 03 – Market Background
The associated industry assessment of the Oncology Nutrition Market is carried out in this section. The macroeconomic factors affecting the growth of the Oncology Nutrition Market are provided in this section and the impact of these macroeconomic indicators on the Oncology Nutrition Market is analyzed. The processing overview and technological advancements in the Oncology Nutrition Market are also provided.
Chapter 04 – Oncology Nutrition Market Value Chain
Profit margins at each level of the Oncology Nutrition Market are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the Oncology Nutrition Market.
Chapter 05 – Market Dynamics
The drivers and restraints impacting the growth of the Oncology Nutrition Market are explained in this chapter. Opportunities and ongoing trends in the Oncology Nutrition Market are also comprehensively discussed.
Chapter 06 – Oncology Nutrition Market - Pricing Analysis
This chapter includes global as well as regional pricing analysis by product type. The pricing influencing factors are also explained in this chapter. The readers can understand the manufacturer level, distributor level as well as retail level pricing analysis for 2022 and 2032.
Chapter 07 – Oncology Nutrition Market Demand Analysis and Forecast 2022-2032
This chapter includes a detailed analysis of the historical Oncology Nutrition Market (2014-2021), along with an opportunity analysis for the forecast period (2022-2032). Readers can also find the absolute $ opportunity for the current year (2022) and incremental opportunity for the forecast period (2022-2032).
Chapter 8 – Global Oncology Nutrition Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Cancer Type
Based on the Cancer Type, the Oncology Nutrition Market is segmented into Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Pancreatic Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Others. In this chapter, readers can find information about key trends and developments in the Oncology Nutrition Market and market attractive analysis based on the Cancer Type.
Chapter 9 – Global Oncology Nutrition Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By End Use
Based on the End Use, the Oncology Nutrition Market is segmented into Hospitals, Homecare, Specialty Clinics, Others. In this chapter, readers can find information about key trends and developments in the Oncology Nutrition Market and market attractive analysis based on End Use.
Chapter 10 – Global Oncology Nutrition Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Region
This chapter explains how the Oncology Nutrition Market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Southeast Asia & Pacific, China, India, Japan and the Middle East & Africa (MEA).
Chapter 11 – North America Oncology Nutrition Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
This chapter includes detailed analysis of the growth of the North America Oncology Nutrition Market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends and market growth based on Cancer Type, End Use and country of Oncology Nutrition in North America.
Chapter 12 – Latin America Oncology Nutrition Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Oncology Nutrition Market. This chapter also includes the growth prospects of the Oncology Nutrition Market in leading LATAM countries such as Brazil, Mexico, and rest of the Latin America region.
Chapter 13 – Eastern Europe Oncology Nutrition Market Analysis 2014-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Eastern Europe Oncology Nutrition Market, along with a country-wise assessment that includes Poland, Czech Republic and Rest of Eastern Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Eastern Europe.
Chapter 14 – Western Europe Oncology Nutrition Market Analysis 2014-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Western Europe Oncology Nutrition Market, along with a country-wise assessment that includes the U.K., France, Germany and Rest of Western Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Western Europe.
Chapter 15 – APEJ Oncology Nutrition Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find thorough information about the growth parameters of the APEJ Oncology Nutrition Market during the period 2022-2032.
Chapter 16 – Japan Oncology Nutrition Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find important factors that can make a huge impact on the growth of the Oncology Nutrition Market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of drivers, restraints, and trends in the Japan Oncology Nutrition Market.
Chapter 17 – MEA Oncology Nutrition Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
This chapter provides information on how the Oncology Nutrition Market will grow in the major countries in MEA region, such as GCC Countries, South Africa and Rest of MEA during the period 2022-2032.
Chapter 18 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Oncology Nutrition Market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments.
Chapter 19 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 20 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Oncology Nutrition Market.
Companies Mentioned
FMC Corporation
Danone India
Abbott
Aceto
B. Braun Melsungen AG
Baxter
Fresenius Kabi AG
Global Health Products, Inc.
Hormel Foods Corporation
Mead Johnson & Company, LLC
Meiji Holdings Co., Ltd
Nestlé S.A.
BioSig Technologies, Inc.
Auris Health, Inc.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Product Life Cycle Analysis
- 3.5. Supply Chain Analysis
- 3.5.1. Supply Side Participants and their Roles
- 3.5.1.1. Producers
- 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
- 3.5.1.3. Wholesalers and Distributors
- 3.5.2. Value Added and Value Created at Node in the Supply Chain
- 3.5.3. List of Raw Material Suppliers
- 3.5.4. List of Existing and Potential Buyer’s
- 3.6. Investment Feasibility Matrix
- 3.7. Value Chain Analysis
- 3.7.1. Profit Margin Analysis
- 3.7.2. Wholesalers and Distributors
- 3.7.3. Retailers
- 3.8. PESTLE and Porter’s Analysis
- 3.9. Regulatory Landscape
- 3.9.1. By Key Regions
- 3.9.2. By Key Countries
- 3.10. Regional Parent Market Outlook
- 3.11. Production and Consumption Statistics
- 3.12. Import and Export Statistics
- 4. Global Oncology Nutrition Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Cancer Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Bn) Analysis By Cancer Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Cancer Type, 2022-2032
- 5.3.1. Head & Neck
- 5.3.2. Stomach & Gastrointestinal
- 5.3.3. Pancreatic
- 5.3.4. Breast
- 5.3.5. Liver
- 5.3.6. Other Cancer Types
- 5.4. Y-o-Y Growth Trend Analysis By Cancer Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Cancer Type, 2022-2032
- 6. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By End-Use
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Bn) Analysis By End-Use, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-Use, 2022-2032
- 6.3.1. Hospitals
- 6.3.2. Home Care
- 6.3.3. Other End-Uses
- 6.4. Y-o-Y Growth Trend Analysis By End-Use, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By End-Use, 2022-2032
- 7. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021
- 7.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. Asia Pacific
- 7.3.5. MEA
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country
- 8.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
- 8.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
- 8.2.1. By Country
- 8.2.1.1. U.S.
- 8.2.1.2. Canada
- 8.2.2. By Cancer Type
- 8.2.3. By End-Use
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Cancer Type
- 8.3.3. By End-Use
- 8.4. Key Takeaways
- 9. Latin America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Argentina
- 9.2.1.4. Chile
- 9.2.1.5. Peru
- 9.2.1.6. Rest of Latin America
- 9.2.2. By Cancer Type
- 9.2.3. By End-Use
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Cancer Type
- 9.3.3. By End-Use
- 9.4. Key Takeaways
- 10. Europe Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. Italy
- 10.2.1.3. France
- 10.2.1.4. U.K.
- 10.2.1.5. Spain
- 10.2.1.6. Russia
- 10.2.1.7. BENELUX
- 10.2.1.8. Rest of Europe
- 10.2.2. By Cancer Type
- 10.2.3. By End-Use
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Cancer Type
- 10.3.3. By End-Use
- 10.4. Key Takeaways
- 11. Asia Pacific Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.1.4. Rest of Asia Pacific
- 11.2.2. By Cancer Type
- 11.2.3. By End-Use
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Cancer Type
- 11.3.3. By End-Use
- 11.4. Key Takeaways
- 12. MEA Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. GCC Countries
- 12.2.1.2. South Africa
- 12.2.1.3. Turkey
- 12.2.1.4. Rest of MEA
- 12.2.2. By Cancer Type
- 12.2.3. By End-Use
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Cancer Type
- 12.3.3. By End-Use
- 12.4. Key Takeaways
- 13. Key Countries Oncology Nutrition Analysis
- 13.1. U.S.
- 13.1.1. Pricing Analysis
- 13.1.2. Market Share Analysis, 2021
- 13.1.2.1. By Cancer Type
- 13.1.2.2. By End-Use
- 13.2. Canada
- 13.2.1. Pricing Analysis
- 13.2.2. Market Share Analysis, 2021
- 13.2.2.1. By Cancer Type
- 13.2.2.2. By End-Use
- 13.3. Brazil
- 13.3.1. Pricing Analysis
- 13.3.2. Market Share Analysis, 2021
- 13.3.2.1. By Cancer Type
- 13.3.2.2. By End-Use
- 13.4. Mexico
- 13.4.1. Pricing Analysis
- 13.4.2. Market Share Analysis, 2021
- 13.4.2.1. By Cancer Type
- 13.4.2.2. By End-Use
- 13.5. Argentina
- 13.5.1. Pricing Analysis
- 13.5.2. Market Share Analysis, 2021
- 13.5.2.1. By Cancer Type
- 13.5.2.2. By End-Use
- 13.6. Chile
- 13.6.1. Pricing Analysis
- 13.6.2. Market Share Analysis, 2021
- 13.6.2.1. By Cancer Type
- 13.6.2.2. By End-Use
- 13.7. Peru
- 13.7.1. Pricing Analysis
- 13.7.2. Market Share Analysis, 2021
- 13.7.2.1. By Cancer Type
- 13.7.2.2. By End-Use
- 13.8. Germany
- 13.8.1. Pricing Analysis
- 13.8.2. Market Share Analysis, 2021
- 13.8.2.1. By Cancer Type
- 13.8.2.2. By End-Use
- 13.9. Italy
- 13.9.1. Pricing Analysis
- 13.9.2. Market Share Analysis, 2021
- 13.9.2.1. By Cancer Type
- 13.9.2.2. By End-Use
- 13.10. France
- 13.10.1. Pricing Analysis
- 13.10.2. Market Share Analysis, 2021
- 13.10.2.1. By Cancer Type
- 13.10.2.2. By End-Use
- 13.11. U.K.
- 13.11.1. Pricing Analysis
- 13.11.2. Market Share Analysis, 2021
- 13.11.2.1. By Cancer Type
- 13.11.2.2. By End-Use
- 13.12. Spain
- 13.12.1. Pricing Analysis
- 13.12.2. Market Share Analysis, 2021
- 13.12.2.1. By Cancer Type
- 13.12.2.2. By End-Use
- 13.13. Russia
- 13.13.1. Pricing Analysis
- 13.13.2. Market Share Analysis, 2021
- 13.13.2.1. By Cancer Type
- 13.13.2.2. By End-Use
- 13.14. BENELUX
- 13.14.1. Pricing Analysis
- 13.14.2. Market Share Analysis, 2021
- 13.14.2.1. By Cancer Type
- 13.14.2.2. By End-Use
- 13.15. China
- 13.15.1. Pricing Analysis
- 13.15.2. Market Share Analysis, 2021
- 13.15.2.1. By Cancer Type
- 13.15.2.2. By End-Use
- 13.16. Japan
- 13.16.1. Pricing Analysis
- 13.16.2. Market Share Analysis, 2021
- 13.16.2.1. By Cancer Type
- 13.16.2.2. By End-Use
- 13.17. South Korea
- 13.17.1. Pricing Analysis
- 13.17.2. Market Share Analysis, 2021
- 13.17.2.1. By Cancer Type
- 13.17.2.2. By End-Use
- 13.18. GCC Countries
- 13.18.1. Pricing Analysis
- 13.18.2. Market Share Analysis, 2021
- 13.18.2.1. By Cancer Type
- 13.18.2.2. By End-Use
- 13.19. South Africa
- 13.19.1. Pricing Analysis
- 13.19.2. Market Share Analysis, 2021
- 13.19.2.1. By Cancer Type
- 13.19.2.2. By End-Use
- 13.20. Turkey
- 13.20.1. Pricing Analysis
- 13.20.2. Market Share Analysis, 2021
- 13.20.2.1. By Cancer Type
- 13.20.2.2. By End-Use
- 14. Market Structure Analysis
- 14.1. Competition Dashboard
- 14.2. Competition Benchmarking
- 14.3. Market Share Analysis of Top Players
- 14.3.1. By Regional
- 14.3.2. By Cancer Type
- 14.3.3. By End-Use
- 15. Competition Analysis
- 15.1. Competition Deep Dive
- 15.1.1. Abbott Laboratories
- 15.1.1.1. Overview
- 15.1.1.2. Product Portfolio
- 15.1.1.3. Profitability by Market Segments
- 15.1.1.4. Sales Footprint
- 15.1.1.5. Strategy Overview
- 15.1.1.5.1. Marketing Strategy
- 15.1.1.5.2. Product Strategy
- 15.1.1.5.3. Channel Strategy
- 15.1.2. B. Braun Melsungen AG
- 15.1.2.1. Overview
- 15.1.2.2. Product Portfolio
- 15.1.2.3. Profitability by Market Segments
- 15.1.2.4. Sales Footprint
- 15.1.2.5. Strategy Overview
- 15.1.2.5.1. Marketing Strategy
- 15.1.2.5.2. Product Strategy
- 15.1.2.5.3. Channel Strategy
- 15.1.3. Baxter International Inc.
- 15.1.3.1. Overview
- 15.1.3.2. Product Portfolio
- 15.1.3.3. Profitability by Market Segments
- 15.1.3.4. Sales Footprint
- 15.1.3.5. Strategy Overview
- 15.1.3.5.1. Marketing Strategy
- 15.1.3.5.2. Product Strategy
- 15.1.3.5.3. Channel Strategy
- 15.1.4. Fresenius Kabi AG
- 15.1.4.1. Overview
- 15.1.4.2. Product Portfolio
- 15.1.4.3. Profitability by Market Segments
- 15.1.4.4. Sales Footprint
- 15.1.4.5. Strategy Overview
- 15.1.4.5.1. Marketing Strategy
- 15.1.4.5.2. Product Strategy
- 15.1.4.5.3. Channel Strategy
- 15.1.5. Hormel Foods Corporation
- 15.1.5.1. Overview
- 15.1.5.2. Product Portfolio
- 15.1.5.3. Profitability by Market Segments
- 15.1.5.4. Sales Footprint
- 15.1.5.5. Strategy Overview
- 15.1.5.5.1. Marketing Strategy
- 15.1.5.5.2. Product Strategy
- 15.1.5.5.3. Channel Strategy
- 15.1.6. Mead Johnson & Company LLC
- 15.1.6.1. Overview
- 15.1.6.2. Product Portfolio
- 15.1.6.3. Profitability by Market Segments
- 15.1.6.4. Sales Footprint
- 15.1.6.5. Strategy Overview
- 15.1.6.5.1. Marketing Strategy
- 15.1.6.5.2. Product Strategy
- 15.1.6.5.3. Channel Strategy
- 15.1.7. Nestle S.A.
- 15.1.7.1. Overview
- 15.1.7.2. Product Portfolio
- 15.1.7.3. Profitability by Market Segments
- 15.1.7.4. Sales Footprint
- 15.1.7.5. Strategy Overview
- 15.1.7.5.1. Marketing Strategy
- 15.1.7.5.2. Product Strategy
- 15.1.7.5.3. Channel Strategy
- 15.1.8. Pfizer Inc.
- 15.1.8.1. Overview
- 15.1.8.2. Product Portfolio
- 15.1.8.3. Profitability by Market Segments
- 15.1.8.4. Sales Footprint
- 15.1.8.5. Strategy Overview
- 15.1.8.5.1. Marketing Strategy
- 15.1.8.5.2. Product Strategy
- 15.1.8.5.3. Channel Strategy
- 16. Assumptions & Acronyms Used
- 17. Research Methodology
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook